Literature DB >> 17684203

Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients.

Juan Ruano1, José López-Miranda, Rafael de la Torre, Javier Delgado-Lista, Javier Fernández, Javier Caballero, María Isabel Covas, Yolanda Jiménez, Pablo Pérez-Martínez, Carmen Marín, Francisco Fuentes, Francisco Pérez-Jiménez.   

Abstract

BACKGROUND: Oxidative stress associated with postprandial lipemia contributes to endothelial dysfunction, which shifts hemostasis to a more thrombogenic state.
OBJECTIVE: We investigated whether a high concentration of phenols in olive oil can partly reverse this phenomenon.
DESIGN: Twenty-one hypercholesterolemic volunteers received 2 breakfasts rich in olive oils with different phenolic contents (80 or 400 ppm) according to a randomized, sequential crossover design. Plasma concentrations of lipid fractions, factor VII antigen (FVIIag), activated factor VII (FVIIa), and plasminogen activator inhibitor-1 (PAI-1) activity were measured at baseline and postprandially.
RESULTS: Concentrations of FVIIa increased less (P = 0.018) and plasma PAI-1 activity decreased more (P = 0.021) 2 h after the high-phenol meal than after the low-phenol meal. FVIIa concentrations 120 min after intake of the olive oil with a high phenol content correlated positively with fasting plasma triacylglycerols (P = 0.001), area under the curve (AUC) of triacylglycerols (P = 0.001), and AUC of nonesterified fatty acids (P = 0.024) and negatively with hydroxytyrosol plasma concentrations at 60 min (P = 0.039) and fasting HDL-cholesterol concentrations (P = 0.005). PAI-1 positively correlated with homeostasis model assessment of insulin resistance (P = 0.005) and fasting triacylglycerols (P = 0.025) and inversely with adiponectin (P = 0.026). In a multivariate analysis, the AUCs of nonesterified fatty acids (R(2) = 0.467; beta: 0.787; SE: 0.02; P < 0.001) and adiponectin (R(2) = 0.232; beta: -1.594; SE: 0.629; P < 0.05) were the strongest predictors of plasma FVIIa and PAI-1, respectively.
CONCLUSIONS: A virgin olive oil with a high content of phenolic compounds changes the postprandial hemostatic profile to a less thrombogenic state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684203     DOI: 10.1093/ajcn/86.2.341

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  17 in total

1.  Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil.

Authors:  Antonio Camargo; Juan Ruano; Juan M Fernandez; Laurence D Parnell; Anabel Jimenez; Monica Santos-Gonzalez; Carmen Marin; Pablo Perez-Martinez; Marino Uceda; Jose Lopez-Miranda; Francisco Perez-Jimenez
Journal:  BMC Genomics       Date:  2010-04-20       Impact factor: 3.969

Review 2.  Biological activities of phenolic compounds present in virgin olive oil.

Authors:  Sara Cicerale; Lisa Lucas; Russell Keast
Journal:  Int J Mol Sci       Date:  2010-02-02       Impact factor: 5.923

Review 3.  Mediterranean diet and health status: Active ingredients and pharmacological mechanisms.

Authors:  Lukas Schwingshackl; Jakub Morze; Georg Hoffmann
Journal:  Br J Pharmacol       Date:  2019-07-25       Impact factor: 8.739

4.  Additive regulation of adiponectin expression by the mediterranean diet olive oil components oleic Acid and hydroxytyrosol in human adipocytes.

Authors:  Egeria Scoditti; Marika Massaro; Maria Annunziata Carluccio; Mariangela Pellegrino; Martin Wabitsch; Nadia Calabriso; Carlo Storelli; Raffaele De Caterina
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

5.  Effects of a diet higher in carbohydrate/lower in fat versus lower in carbohydrate/higher in monounsaturated fat on postmeal triglyceride concentrations and other cardiovascular risk factors in type 1 diabetes.

Authors:  Irene Strychar; Jeffrey S Cohn; Geneviève Renier; Michèle Rivard; Nahla Aris-Jilwan; Hugues Beauregard; Sara Meltzer; André Bélanger; Richard Dumas; Alain Ishac; Farouk Radwan; Jean-François Yale
Journal:  Diabetes Care       Date:  2009-06-18       Impact factor: 19.112

6.  Effects of rs7903146 variation in the Tcf7l2 gene in the lipid metabolism of three different populations.

Authors:  Pablo Perez-Martinez; Ana I Perez-Caballero; Antonio Garcia-Rios; Elena M Yubero-Serrano; Antonio Camargo; Maria J Gomez-Luna; Carmen Marin; Purificacion Gomez-Luna; Aldona Dembinska-Kiec; Fernando Rodriguez-Cantalejo; Francisco J Tinahones; Helen M Roche; Francisco Perez-Jimenez; Jose Lopez-Miranda; Javier Delgado-Lista
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

7.  Antioxidant Effects of a Hydroxytyrosol-Based Pharmaceutical Formulation on Body Composition, Metabolic State, and Gene Expression: A Randomized Double-Blinded, Placebo-Controlled Crossover Trial.

Authors:  Carmela Colica; Laura Di Renzo; Domenico Trombetta; Antonella Smeriglio; Sergio Bernardini; Giorgia Cioccoloni; Renata Costa de Miranda; Paola Gualtieri; Paola Sinibaldi Salimei; Antonino De Lorenzo
Journal:  Oxid Med Cell Longev       Date:  2017-08-09       Impact factor: 6.543

8.  Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial.

Authors:  Stacey Lockyer; Ian Rowland; Jeremy Paul Edward Spencer; Parveen Yaqoob; Welma Stonehouse
Journal:  Eur J Nutr       Date:  2016-03-07       Impact factor: 5.614

Review 9.  Phenolic Compounds Isolated from Olive Oil as Nutraceutical Tools for the Prevention and Management of Cancer and Cardiovascular Diseases.

Authors:  Patricia Reboredo-Rodríguez; Alfonso Varela-López; Tamara Y Forbes-Hernández; Massimiliano Gasparrini; Sadia Afrin; Danila Cianciosi; Jiaojiao Zhang; Piera Pia Manna; Stefano Bompadre; José L Quiles; Maurizio Battino; Francesca Giampieri
Journal:  Int J Mol Sci       Date:  2018-08-06       Impact factor: 5.923

10.  Antithrombotic effect of repeated doses of the ethanolic extract of local olive (Olea europaea L.) leaves in rabbits.

Authors:  Abdallah M Dub; Aisha M Dugani
Journal:  Libyan J Med       Date:  2013-05-22       Impact factor: 1.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.